Literature DB >> 16829120

Surgery and radiotherapy in vulvar cancer.

J A de Hullu1, A G J van der Zee.   

Abstract

The majority of patients with vulvar cancer have squamous cell carcinomas (SCC). The cornerstone of the treatment is surgery. Radical vulvectomy with "en bloc" inguinofemoral lymphadenectomy has led to a favorable prognosis but with impressive morbidity. Nowadays, treatment is more individualized with wide local excision with uni- or bilateral inguinofemoral lymphadenectomy via separate incisions as the standard treatment for early stage patients with SCC of the vulva with depth of invasion >1 mm without suspicious groins. In case of more than one intranodal lymph node metastasis and/or extranodal growth, postoperative radiotherapy on the groins and pelvis is warranted. Until now there is a limited role for primary radiotherapy on the vulva and/or groins in early stage disease. The sentinel lymph node (SLN) procedure with the combined technique (preoperative lymphoscintigraphy with a radioactive tracer and intraoperative blue dye) is a promising staging technique for patients with early stage vulvar cancer. The safety of clinical implementation of the SLN procedure and the role of additional histopathological techniques of the SLNs need to be further investigated before its wide-scale application. Patients with advanced vulvar cancer are difficult to treat. One of the problems in patients with locally advanced vulvar cancer is the high incidence of concomitant bulky lymph nodes in the groin(s). Ultraradical surgery in case of resectable disease will lead to impressive morbidity because of the exenterative-type procedure. (Chemo)radiation with or without surgery should be regarded as the first choice for patients with locally advanced vulvar cancer only when primary surgery will necessitate performance of a stoma. Further studies are needed to determine the optimal combined modality treatment in these patients. Due to the fact that vulvar cancer is a rare disease, further clinical studies will only be possible, when international collaborative groups will join forces in order to perform clinical trials, in which different treatment options such as SLN procedure, primary radiotherapy on the groins and multimodality treatment for advanced disease will be investigated.

Entities:  

Mesh:

Year:  2006        PMID: 16829120     DOI: 10.1016/j.critrevonc.2006.02.008

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  22 in total

1.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

2.  Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.

Authors:  Merlijn Hutteman; Joost R van der Vorst; Katja N Gaarenstroom; Alexander A W Peters; J Sven D Mieog; Boudewijn E Schaafsma; Clemens W G M Löwik; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  Am J Obstet Gynecol       Date:  2011-07-30       Impact factor: 8.661

3.  Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients.

Authors:  Sonia Prader; Andreas du Bois; Philipp Harter; Elisabeth Breit; Stephanie Schneider; Thais Baert; Florian Heitz; Alexander Traut; Sarah Ehmann; Nina Pauly; Sebastian Heikaus; Detlef Moka; Beyhan Ataseven
Journal:  Arch Gynecol Obstet       Date:  2020-02-13       Impact factor: 2.344

4.  Sentinel node procedure in vulvar carcinoma during pregnancy: A case report.

Authors:  T A J Nijman; E M Schutter; F Amant
Journal:  Gynecol Oncol Case Rep       Date:  2012-02-13

5.  Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins.

Authors:  Tanja Ignatov; Holm Eggemann; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-02       Impact factor: 4.553

6.  Exploratory Study of the Clinical Value of Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green in Vulvar Cancer Patients.

Authors:  Franziska Siegenthaler; Sara Imboden; Laura Knabben; Stefan Mohr; Andrea Papadia; Michael D Mueller
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 7.  Chemoradiation for advanced primary vulval cancer.

Authors:  T S Shylasree; Andrew Bryant; Robert Ej Howells
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

8.  Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

Authors:  Beatriz de Melo Maia; André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Glauco Baiocchi; Flávia Munhoz Cestari; Monica Maria Stiepcich; Ludmila Thomé Domingues Chinen; Kátia C Carvalho; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

9.  Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva.

Authors:  Sara Iacoponi; Ignacio Zapardiel; Maria Dolores Diestro; Alicia Hernandez; Javier De Santiago
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

10.  Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma.

Authors:  M D Trietsch; A A W Peters; K N Gaarenstroom; S H L van Koningsbrugge; N T ter Haar; E M Osse; N Halbesma; G J Fleuren
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.